MARKET

CORT

CORT

Corcept Therapeutics Inc
NASDAQ
72.77
+1.29
+1.80%
After Hours: 74.00 +1.23 +1.69% 18:55 05/02 EDT
OPEN
71.88
PREV CLOSE
71.48
HIGH
74.22
LOW
71.17
VOLUME
1.23M
TURNOVER
--
52 WEEK HIGH
117.33
52 WEEK LOW
22.60
MARKET CAP
7.72B
P/E (TTM)
58.48
1D
5D
1M
3M
1Y
5Y
1D
Positive Outlook for Corcept Therapeutics: Buy Rating Backed by Strong Financial Guidance and Pipeline Advancements
TipRanks · 2d ago
LIVE MARKETS-Gauging the seat grab in index musical chairs
Reuters · 3d ago
Should iShares Core S&P Small-Cap ETF (IJR) Be on Your Investing Radar?
NASDAQ · 4d ago
Should Invesco S&P SmallCap Momentum ETF (XSMO) Be on Your Investing Radar?
NASDAQ · 4d ago
CORCEPT THERAPEUTICS TO ANNOUNCE FIRST QUARTER FINANCIAL RESULTS, PROVIDE CORPORATE UPDATE AND HOST CONFERENCE CALL
Barchart · 5d ago
Weekly Report: what happened at CORT last week (0421-0425)?
Weekly Report · 5d ago
3 Healthcare Stocks That Concern Us
Barchart · 5d ago
Piper Sandler Reaffirms Their Buy Rating on Corcept Therapeutics (CORT)
TipRanks · 04/25 10:34
More
About CORT
More
Corcept Therapeutics Incorporated is a commercial-stage company. The Company is engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol. The Company operates through the discovery, development and commercialization of the pharmaceutical products segment. The Company has marketed Korlym (mifepristone) in the United States for the treatment of patients suffering from Cushings syndrome. The Company’s portfolio of selective cortisol modulators consists of four series totaling approximately 1,000 compounds. Its portfolio of selective cortisol modulators consists of relacorilant, dazucorilant and miricorilant. Korlyms active ingredient, mifepristone, reduces the binding of excess cortisol to the GR, it can modulate the effects of abnormal levels and release patterns of cortisol without compromising cortisols healthy functions and rhythms.
Recently
Symbol
Price
%Change

Webull offers Corcept Therapeutics Inc stock information, including NASDAQ: CORT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CORT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CORT stock methods without spending real money on the virtual paper trading platform.